Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03028987 · ClinicalTrials.gov registry record · Phase 4
Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031)
A Phase 4 study, sponsored by Stanford University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT03028987: Clinical Trial Phase 4 study, sponsored by Stanford University.
NCT03028987 is a Phase 4 study that was terminated before completion, run by Stanford University. The registered enrollment target is 10 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03028987, a Phase 4 study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is provide a better understanding of the adaptive immune response to the licensed flu vaccines. The investigators hope the information learned from this study will help identify and describe important factors of influenza immunity especially of or specific proteins associated with the T-cell immune response.
Primary Outcome
Number of individual twins who received either LAIV or IIV4 as dictated by their group assignment
Interventions
- BIOLOGICAL Fluzone®
- BIOLOGICAL FluMist®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-11-19 |
| Est. Completion | 2015-11-18 |
| Phase | Phase 4 |
Why NCT03028987 stopped before completion
NCT03028987 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Fluzone® is the first listed.
NCT03028987 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03028987 about?
NCT03028987 is a clinical study titled "Adaptive Immune Responses and Repertoire in Influenza Vaccination and Infection (SLVP031)". The purpose of this study is provide a better understanding of the adaptive immune response to the licensed flu vaccines. The investigators hope the information learned from this study will help identify and describe important factors of influenza immunity especially of or specific proteins associat...
What is the current status of trial NCT03028987?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2014-11-19. Estimated completion is 2015-11-18.
What interventions are being tested in trial NCT03028987?
The interventions under investigation include: Fluzone® (BIOLOGICAL), FluMist® (BIOLOGICAL).
Who is sponsoring clinical trial NCT03028987?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03028987's enrollment target sits among peer trials
10 1940th of 2000 higher than 33 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI